Gsk Plc (GSK.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | GSK.LN | ||||
| Company | Gsk Plc | ||||
| Price Information | |||||
| Exchange | LSE | ||||
| Open | 1,955.500 | ||||
| High | 1,968.500 | ||||
| Low | 1,940.000 | ||||
| Latest | 1,950.000 | ||||
| Change | -8.000 | ||||
| % Change | -0.41% | ||||
| Volume | 6,744,478 | ||||
| 20-Day Average Volume | 6,072,438 | ||||
| Previous Close | 1,958.000 | ||||
| Industry | N/A | ||||
| Has Options | No | ||||
| Technicals | |||||
| 20-Day Moving Average | 1,912.225 | ||||
| 20-Day Raw Stochastic | 51.90% | ||||
| 20-Day Relative Strength | 51.15 | ||||
| Weighted Alpha | +30.29 | ||||
| Today's Opinion | Hold | ||||
| Previous Opinion | 16% Buy | ||||
| Last Month's Opinion | 8% Sell | ||||
| Performance | |||||
| 5-Days | |||||
| %Chg | +2.44% since 06/09/26 | ||||
| Low | 1,890.500 on 06/10/26 | ||||
| High | 2,011.000 on 06/12/26 | ||||
| 1-Month | |||||
| %Chg | +4.70% since 05/15/26 | ||||
| Low | 1,690.000 on 05/19/26 | ||||
| High | 2,191.000 on 05/28/26 | ||||
| 3-Month | |||||
| %Chg | -3.75% since 03/16/26 | ||||
| Low | 1,690.000 on 05/19/26 | ||||
| High | 2,202.000 on 04/15/26 | ||||
| 6-Month | |||||
| %Chg | +7.17% since 12/16/25 | ||||
| Low | 1,690.000 on 05/19/26 | ||||
| High | 2,282.000 on 02/18/26 | ||||
| Key Statistics | |||||
| Market Capitalization, $K | 79,535,166 | ||||
| Shares Outstanding, K | 4,010,456 | ||||
| Annual Sales | 32,667,000,000 | ||||
| Annual Net Income | 5,716,000,000 | ||||
| Last Quarter Sales | 7,629,000,000 | ||||
| Last Quarter Net Income | 1,737,000,000 | ||||
| 60-Month Beta | N/A | ||||
| Per-Share Information | |||||
| Most Recent Earnings | 0.43 on 04/29/26 | ||||
| Earnings Date | N/A | ||||
| Most Recent Dividend | 0.170 on 05/14/26 | ||||
| Next Ex-Dividends Date | 05/14/26 | ||||
| Ratios | |||||
| Price/Earnings ttm | 13.96 | ||||